Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride reduces hair growth better, but spironolactone has more side effects.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

SHBG may be a useful early indicator and treatment target for PCOS.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Androgen use may increase the risk of stroke, but more research is needed.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Surgery successfully treated a hidden ovarian tumor causing hair loss and excess hair growth in a postmenopausal woman.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Certain gene variants are linked to severe acne, especially in males.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

More research is needed to determine if iron deficiency causes hair loss.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.